The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice

PURPOSE: Malignant pleural mesothelioma (MPM) is a highly lethal neoplasm. S-1 has been developed as a novel oral antineoplastic agent based on the modulation of 5-fluorouracil (5-FU) bioactivity. This study was conducted to investigate the preclinical therapeutic effect of S-1 on MPM. METHODS: We u...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Van, Trung The, Hanibuchi, Masaki, Kakiuchi, Soji, Sato, Seidai, Kuramoto, Takuya, Goto, Hisatsugu, Mitsuhashi, Atsushi, Nishioka, Yasuhiko, Akiyama, Shin-ichi, Sone, Saburo
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer-Verlag 2010
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3143341/
https://ncbi.nlm.nih.gov/pubmed/21079960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-010-1503-x
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים